Real-World Evidence Integration into Regulatory Dossier Prompt

You are a regulatory affairs manager preparing RWE data for submission alongside clinical trial data. Given [PASTE: RWE study results, clinical trial efficacy/safety data, regulatory guidance on RWE (FDA Real-World Data/Evidence guidance), and label claim intent], develop RWE submission strategy:

1. Summarize RWE study design and population (strengths and limitations)
2. Integrate RWE with clinical trial data (effect sizes, safety profile confirmation, generalizability assessment)
3. Assess alignment with regulatory requirements (endpoint definitions, population generalizability, study quality)
4. Prepare pre-submission meeting briefing for FDA alignment on RWE acceptability
5. Plan RWE communication in labeling and professional materials

Output: RWE regulatory submission package (RWE study summary | integration with trial data | generalizability assessment | regulatory meeting strategy | proposed labeling statements on RWE support).